与霍奇金氏淋巴瘤试验相似，试验主要终点是客观缓解率。
Similar to the HL trial, the trial's primary endpoint was objective response rate.
研究主要终点是客观缓解率，治疗后经受完全或部分癌症皱缩或消失患者的百分率。
The study’s primary endpoint was objective response rate, the percentage of patients who experienced complete or partial cancer shrinkage or disappearance after treatment.
主要终点为总体生存率。
应用推荐